Review of the cardiovascular safety of dipeptidyl peptidase-4 inhibitors and the clinical relevance of the CAROLINA trial

Cardiovascular (CV) disease (CVD) is a well-recognized complication of type 2 diabetes mellitus (T2DM) and there is a clinical need for glucose-lowering therapies that do not further increase CV risk in this p...

Source: BMC Cardiovascular Disorders - March 15, 2019 Category: Cardiology Authors: Marile Santamarina and Curt J. Carlson Tags: Research article Source Type: research